10/14/2008

NeoChord has received venture capital funding from Indiana-based Clarian Health Ventures. The biotech startup firm is working on a Mayo Clinic device aimed at treating mitral-valve regurgitation in cardiac patients without the need for open-heart surgery.

Related Summaries